STUELPNAGEL JOHN R
SEC insider (Form 3/4/5 filer). CIK 0001189140. Director at 10x Genomics, Inc. (TXG). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in PLEASANTON, CA.
Companies STUELPNAGEL JOHN R has filed insider reports for
- 10x Genomics, Inc. (TXG): Director
STUELPNAGEL JOHN R
CIK: 0001189140
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)5 (71.4%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (28.6%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TXG
10x Genomics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 3, 2026TXG
10x Genomics, Inc.
SaleDirect6.8K shares at avg. $62.11$423K - Sep 3, 2026TXG
10x Genomics, Inc.
SaleDirect7K shares at avg. $60.66$425K - Sep 3, 2026TXG
10x Genomics, Inc.
SaleDirect6.2K shares at avg. $62.61$387K - Aug 11, 2026TXG
10x Genomics, Inc.
SaleDirect3K shares at avg. $58.73$176K - Aug 11, 2026TXG
10x Genomics, Inc.
SaleDirect17K shares at avg. $57.58$979K - Jun 4, 2026TXG
10x Genomics, Inc.
AwardDirect8.8K shares- - Jun 3, 2025TXG
10x Genomics, Inc.
AwardDirect15.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 | TXG 10x Genomics, Inc. | Sale | 6,814 | $62.11 | $423,205 | Direct |
| Sep 3, 2026 | TXG 10x Genomics, Inc. | Sale | 7,012 | $60.66 | $425,333 | Direct |
| Sep 3, 2026 | TXG 10x Genomics, Inc. | Sale | 6,174 | $62.61 | $386,533 | Direct |
| Aug 11, 2026 | TXG 10x Genomics, Inc. | Sale | 3,000 | $58.73 | $176,175 | Direct |
| Aug 11, 2026 | TXG 10x Genomics, Inc. | Sale | 17,000 | $57.58 | $978,880 | Direct |
| Jun 4, 2026 | TXG 10x Genomics, Inc. | Award | 8,829 | - | $0 | Direct |
| Jun 3, 2025 | TXG 10x Genomics, Inc. | Award | 15,357 | - | - | Direct |
1-7 of 7 transactions